May 24, 2023 9:25am EDT ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
May 18, 2023 4:01pm EDT ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference
May 10, 2023 4:05pm EDT ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles
Apr 20, 2023 4:05pm EDT ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism™ Neuro Laser Therapy System
Apr 18, 2023 4:05pm EDT ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model
Apr 13, 2023 4:05pm EDT ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil
Apr 11, 2023 4:05pm EDT ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS
Mar 28, 2023 4:05pm EDT ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform